Multinational science and technology company Merck KGgA announced on Monday that it has closed a deal with Swiss biotech company Debiopharm to develop and market its Xevinapant drug for head and neck cancer. The deal is estimated to be worth 900 million euros ($1.08 billion).
The terms of the deal...
After 33 years of operational difficulties, American vaccine development company Novavax has finally received approval for its COVID-19 vaccine shot. According to testing results, the Novavax vaccine has efficacy rates that are of a similar level to the vaccines developed by Pfizer and BioNTech as well as Moderna.
As the...
Johnson & Johnson's single-dose coronavirus shot recently received emergency use approval from the U.S. Food and Drug Administration on Saturday evening, making it the third COVID vaccine available for use in the United States.
Following the conclusion of early-phase clinical trials, the pharmaceutical giant submitted data regarding its results to...
Moderna shares gained 2.2% during premarket trading on Thursday as the biotech company reported a revenue of $570 million during the fourth quarter of 2020. This revenue surge came as a result of skyrocketing sales of the Massachusetts-based company's COVID-19 vaccine, mRNA-1273.
Despite this record-high sales revenue, the biotech firm...
Private equity firm CVC Capital Partners is currently exploring a bid for UK chemical manufacturer Synthomer Plc, according to reports. The Luxembourg-based CVC currently manages approximately $111 billion in secured commitments of private equity, credit, and growth funds across Asia and Europe.
According to insiders who asked to remain anonymous,...
Sanofi and GlaxoSmithKline Plc have resumed trials for their joint COVID-19 vaccine candidate. After being faced with setbacks during their previous trials in the fall, these pharmaceutical manufacturers have improved their shot's formulation. According to a statement on Monday, this was done to improve effectiveness in people 50 years...
After becoming the first African country to begin a national vaccination campaign two weeks ago, Morocco is expected to receive an order of 4 million doses of the AstraZeneca vaccine on Thursday. The doses that are expected to arrive were manufactured by the Serum Institute of India.
According to health...
Brazilian healthcare technology startup Alice raised $33 million in its latest round of funding, the company revealed in a statement on Thursday. The new round was led by the Boston-based venture capital firm ThornTree Capital Partners, with existing investors such as Kaszek Ventures, Canary, and Maya Capital also getting...
Hong Kong Health Secretary Sophia Chan announced on Wednesday that the city plans to ease coronavirus restrictions from February 18th onwards. This will see the reopening of sports and entertainment facilities as well as the extension of dining hours in restaurants.
While catering businesses will be permitted to remain open...
The government of the United Kingdom has reportedly entered into talks with numerous pharmaceutical companies over the possibility of receiving early access to modified versions of existing coronavirus vaccines. This move comes as the United Kingdom looks to secure its place as one of the first countries to receive...